Ding et al. showed that the presence of GSTT1−/− and/or GSTM1−/− showed a higher risk of developing pulmonary fibrosis in patients with chronic obstructive pulmonary disease, which is also one of the most important complications of COVID-19 and characterized by long-term respiratory complications [15]. Here, GSTM1 is linked to pulmonary fibrosis.